Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up
Abstract Purpose Immunotherapy is a promising treatment for cancers but should be optimized for malignant gliomas. Because of immune privilege feature of the brain, local administration of immunotherapy may be a promising strategy for malignant glioma treatment. Identification of patients who may be...
Saved in:
| Main Authors: | Hao Duan, Zhenqiang He, Zhenghe Chen, Yukun Chen, Wanming Hu, Ke Sai, Xiangheng Zhang, Jianchuan Xia, Yongqiang Li, Ranyi Liu, Chaowei Zou, Zhongping Chen, Yonggao Mou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | BMC Immunology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12865-024-00676-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management and survival trends for diffuse gliomas diagnosed at a single neurooncology center in China during 2000 to 2020
by: Depei Li, et al.
Published: (2025-04-01) -
Transposable Element Is Predictive of Chemotherapy- and Immunotherapy-Related Overall Survival in Glioma
by: Bi Peng, et al.
Published: (2025-05-01) -
Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01) -
Immunotherapy of malignant gliomas: a modern view on the problem
by: А. А. Pichugin, et al.
Published: (2024-12-01) -
Evolution of radiotherapy and chemotherapy practice in malignant gliomas
by: Anusheel Munshi, et al.
Published: (2013-05-01)